GlucoTrack, Inc.
Market Cap
$641.23K
P/E Ratio
—
EPS
$-1268.49
Dividend Yield
0.00%
52-Week Range
$1.10 — $30.48
Volume
35.25K
Avg Volume
348.92K
Beta
0.35
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.00
P/B (TTM)
0.48
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-26.59%
ROA (TTM)
-3.12%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.01
Current Ratio
1.53
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.72%
EPS Growth (5Y)
+0.42%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
-0.20%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$8.75
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
567.46K
Float
565.41K
Free Float %
99.64%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
IL
Exchange
NASDAQ
IPO Date
2013-04-25
Employees
11
CEO
Paul V. Goode
Index Membership
—
Website
https://www.glucotrack.com
GlucoTrack, Inc. (GCTK) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $641.23K, GCTK is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare GCTK against other stocks using dozens of fundamental and technical filters.
MHUA
Meihua International Medical Technologies Co., Ltd.
$8.65
+0.23%
$2.74M
POAI
Predictive Oncology Inc.
$1.58
-1.86%
$1.15M
IBO.V
Universal Ibogaine Inc.
$0.01
-50.00%
$1.56M
ASBP
Aspire Biopharma Holdings, Inc.
$0.88
-10.21%
$3.03M
BBLG
Bone Biologics Corporation
$1.24
+1.64%
$2.23M
BRTX
BioRestorative Therapies, Inc.
$0.25
-12.40%
$2.24M
No, GlucoTrack, Inc. (GCTK) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
GlucoTrack, Inc. (GCTK) has a market capitalization of $641,225, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.